Advertisement

Genotoxicity

  • Ingo Stammberger
  • Andreas Czich
  • Knut Braun
Reference work entry

Abstract

The task of the Genetic Toxicology is to use recognized test methods in order to identify the genotoxic or mutagenic potential of pharmaceuticals and chemicals. The genotoxic or mutagenic potential is what we call the potential health risk of a substance with respect to its ability to cause cell mutations. Substances with this potential are known as mutagens and genotoxicity studies, also called mutagenicity studies, help identify such substances.

Keywords

Comet Assay Chromosome Aberration Micronucleus Test OECD Guideline Mouse Lymphoma Cell 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References and Further Reading

  1. Alvares A-P, Bickers D-R, Kappas A (1973) Polychlorinated biphenyls: a new type of inducer of cytochrome P 448 in the liver. Proc Natl Acad Sci USA 70:1321–1325PubMedCrossRefGoogle Scholar
  2. Ames B-N, Durston W-W, Yamasaki E, Lee F-D (1973) Carcinogens are mutagens. A simple test system combining liver homogenate for activation and bacteria for detection. Proc Natl Acad Sci USA 70:2281–2285PubMedCrossRefGoogle Scholar
  3. Ames B-N, McCann J, Yamasaki E (1975) Methods for detecting carcinogens and mutagens with the Salmonella/mammalian microsome mutagenicity test. Mutat Res 31:347–364PubMedCrossRefGoogle Scholar
  4. Ashby J, Lefèvre PA, Burlinson B, Penman MG (1985) An assessment of the in vivo rat hepatocyte DNA repair assay. Mutat Res 156:1–18PubMedCrossRefGoogle Scholar
  5. Ashby J, Trueman RW, Mohammed R, Barber G (1987) Positive and negative control observations for the in vivo/in vitro rat liver assay for unscheduled DNA synthesis (UDS). Mutagenesis 2(6):489–490PubMedCrossRefGoogle Scholar
  6. Bermudez E, Mirsalis JC, Eales HC (1982) Detection of DNA damage in primary cultures of rat hepatocytes following in vivo and in vitro exposure to genotoxic agents. Environ Mutagen 4:667–679PubMedCrossRefGoogle Scholar
  7. Bradley MO, Bhuyan B, Francis MC, Langenbach R, Peterson A, Huberman E (1981) Mutagenesis by chemical agents in V79 Chinese hamster cells: a review and analysis of the literature. A report of the gene-tox program. Mutat Res 87:81–142PubMedCrossRefGoogle Scholar
  8. Bridge BA (1976) Short term screening tests for carcinogens. Nature 261:195–200CrossRefGoogle Scholar
  9. Burlinson J, Tice RR, Speit G, Speit E, Agurell GSY, Collins EAR, Escobar P, Honma M, Kumaravel TS, Nakajima M, Sasaki YF, Thybaud V, Uno Y, Vasquez M, Hartmann A (2007) In vivo comet assay workgroup, part of the fourth international workgroup on genotoxicity testing. Mutat Res 627:31–35PubMedCrossRefGoogle Scholar
  10. Butterworth BE, Ashby J, Bermudez E, Casciano D, Mirsalis J, Probst G, Williams GM (1987) A protocol and guide for the in vivo rat hepatocytes DNA repair assay. Mutat Res 189:123–133PubMedCrossRefGoogle Scholar
  11. Clark L, Hart D, Vojta P, Harrington-Brock K, Barrett J, Moore M, Tindall K (1998) Identification and chromosomal assignment of two heterozygous mutations in the Trp53 gene in L5178Y/Tk + /–3.7.2 C mouse lymphoma cells. Mutagenesis 13:427–439PubMedCrossRefGoogle Scholar
  12. Cleaver JE, Thomas GH (1981) Measurement of unscheduled synthesis by autoradiography. In: Friedberg EC, Hanawalt PC (eds) DNA repair. A laboratory manual of research procedures. Marcel Dekker, New York, pp 277–287Google Scholar
  13. Clive D, Flamm W, Patterson J (1972) A mutational assay system using the thymidine kinase locus in mouse lymphoma cells. Mutat Res 16:77PubMedCrossRefGoogle Scholar
  14. Cole J, Muriel W-J, Bridges B-A (1986) The mutagenicity of sodium fluoride to L5178Y [wild-type and TK+/– (3. 7.2c)] mouse lymphoma cells. Mutagenesis 1:157–167PubMedCrossRefGoogle Scholar
  15. Dearfield KL, Thybaud V, Cimino MC, Custer L, Czich A, Harvey JS, Hester S, Kim JH, Kirkland D, Levy DD, Lorge E, Moore MM, Ouédraogo-Arras G, Schuler M, Suter W, Sweder K, Tarlo K, van Benthem J, van Goethem F, Witt KL (2011) Follow-up actions from positive results of in vitro genetic toxicity testing. Environ Mol Mutagen 52(3):177–204. doi:10.1002/em.20617. Epub 2010 Oct 20. ReviewPubMedCrossRefGoogle Scholar
  16. EC Directive 2000/32/EC, L 136, Annex 4D, B.13/B.14Google Scholar
  17. EEC Directive 2000/32/EC, L 136, B.10., “Mutagenicity – in vitro mammalian chromosome aberration test”, adopted 19 May 2000Google Scholar
  18. EMEA (2006) Guideline on the limits of genotoxic impurities. Committee For Medicinal Products for Human Use, The European Medicines Agency, London, 2006, CPMP/SWP/5199/02, EMEA/CHMP/QWP/251344/2006Google Scholar
  19. Flückiger-Isler S, Baumeister M, Braun K, Gervais V, Hasler-Nguyen N, Reimann R, Van Gompel J, Wunderlich H-G, Engelhardt G (2004) Assessment of the performance of the Ames IITM assay: a collaborative study with 19 coded compounds. Mutat Res 558:181–197PubMedCrossRefGoogle Scholar
  20. Frieauff W, Romagna F (1994) Technical aspects of automatic micronucleus analysis in rodent bone marrow assays. Cell Biol Toxicol 10:283–289PubMedCrossRefGoogle Scholar
  21. Hartmann A, Agurell E, Beevers C, Brendler-Schwaab S, Burlinson B, Clay P, Collins A, Smith A, Speit G, Thybaud V, Tice RR (2003) Recommendations for conducting the in vivo alkaline comet assay. Mutagenesis 18:45–51PubMedCrossRefGoogle Scholar
  22. Hayashi M, MacGregor J-T, Gatehouse D-G, Adler I-D, Blakey D, Dertinger S-D, Krishna G, Morita T, Russo A, Sutou S (2000) In vivo rodent erythrocyte micronucleus assay. II. Some aspects of protocol design including repeated treatments, integration with toxicity testing and automated scoring. Environ Mol Mutagen 35:234–252PubMedCrossRefGoogle Scholar
  23. Howard-Flanders P (1981) Mutagenesis in mammalian cells. Mutat Res 86:307–327PubMedCrossRefGoogle Scholar
  24. ICH S2 (2011) International conference on harmonization. Guidance on genotoxicity testing and data interpretation for phamaceuticals intended for human use S2(R1) 9 Nov 2011. Available at http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Safety/S2_R1/Step2/S2_R1__Guideline.pdf. Accessed 3 Sep 2011
  25. Kamber M, Flückiger-Isler S, Engelhardt G, Jaeckh R, Zeiger E (2009) Comparison of the Ames II and traditional Ames test responses with respect to mutagenicity, strain specificities, need for metabolism and correlation with rodent carcinogenicity. Mutagenesis 24:359–366PubMedCrossRefGoogle Scholar
  26. Kirsch-Volders M (1997) Towards a validation of the micronucleus test. Mutat Res 392:1–4PubMedCrossRefGoogle Scholar
  27. Kirsch-Volders M, Sofuni T, Aardema M, Albertini S, Eastmond D, Fenech M, Ishidate M, Kirchner S, Lorge E, Morita T, Norppa H, Surrales J, Vanhauwaert A, Wakata A (2003) Report from the in vitro micronucleus assay working group. Mutat Res 540:153–163PubMedCrossRefGoogle Scholar
  28. Kroes R, Renwick AG, Cheeseman M, Kleiner J, Mangelsdorf I, Piersma A, Schilter B, Schlatter J, van Schothorst F, Vos JG et al. (2004) Structure-based thresholds of toxicological concern (TTC): guidance for application to substances present at low levels in the diet. Food Chem Toxicol 42:65–83PubMedCrossRefGoogle Scholar
  29. Levin D-E, Hollstein M, Christman M-F, Schwiers E-A, Ames B-N (1982) A new Salmonella tester strain with AT base pairs at the site of mutation detects oxidative mutagens. Proc Natl Acad Sci USA 79:7445–7449, GeneticsPubMedCrossRefGoogle Scholar
  30. Maron D-M, Ames B-N (1983) Revised methods for the Salmonella mutagenicity test. Mutat Res 113:173–215PubMedCrossRefGoogle Scholar
  31. McCann J, Springarn N-E, Kobory J, Ames B-N (1975) Detection of carcinogens as mutagens: bacterial tester strains with R factor plasmids. Proc Natl Acad Sci USA 72:979–983PubMedCrossRefGoogle Scholar
  32. McGovern T, Jacobson-Kram D (2006) Regulation of genotoxic and carcinogenic impurities in drug substances and products. Trends Anal Chem 100(1):681–685Google Scholar
  33. Mirsalis J, Butterworth BE (1980) Detection of unscheduled DNA synthesis in hepatocytes isolated from rats treated with genotoxic agents: an in vivo/in vitro assay for potential carcinogens and mutagens. Carcinogenesis 1:621–625PubMedCrossRefGoogle Scholar
  34. Mirsalis JC, Tyson CK, Butterworth BE (1982) Detection of genotoxic carcinogens in the in vivo-in vitro hepatocyte DNA repair assay. Environ Mutagen 4:553–562PubMedCrossRefGoogle Scholar
  35. Mirsalis JC, Tyson CK, Steinmetz KL et al. (1989) Measurement of unscheduled DNA synthesis and S-phase synthesis in rodent hepatocytes following In Vivo treatment: testing of 24 compounds. Environ Mol Mutagen 14:155–164PubMedCrossRefGoogle Scholar
  36. Mitchell AD, Casciano DA, Meltz ML, Robinson DE, San RHC, Williams GM, Von Halle ES (1983) Unscheduled DNA synthesis tests. A report of the U.S. Environmental Protection Agency. Gene-Tox Program. Mutat Res 123:363–410PubMedCrossRefGoogle Scholar
  37. Mitelman F (ed) (1995) An international system for human cytogenetic nomenclature recommendations of the international standing committee on human cytogenetic nomenclature. S. Karger, BaselGoogle Scholar
  38. Moore MM, Clive D, Hozier JC, Barry E, Howard BE, Batson AG, Turner NT, Sawyer J (1985) Analysis of trifluorothymidine-resistant (TFTr) mutants of L5178Y/TK+/- mouse lymphoma cells. Mutat Res 151:161–174PubMedCrossRefGoogle Scholar
  39. Moore M-M, Doerr C-L (1990) Comparison of chromosome aberration frequency and small-colony TK-deficient mutant frequency in L5178Y/TK(+/–)-3.7.2 C mouse lymphoma cells. Mutagenesis 5:609–614PubMedCrossRefGoogle Scholar
  40. Moore M-M, Honma M, Clements J, Bolcsfoldi G, Cifone M, Delongchamp R, Fellows M, Gollapudi B, Jenkinson P, Kirby P, Kirchner S, Muster W, Myhr B, O’Donovan M, Oliver J, Omori T, Ouldelhkim MC, Pant K, Preston R, Riach C, San R, Stankowski LF Jr, Thakur A, Wakuri S, Yoshimura I (2003) Mouse Lymphoma Assay Workgroup mouse lymphoma thymidine kinase gene mutation assay: international workshop on genotoxicity tests workgroup report – Plymouth, UK 2002. Mutat Res 540(2):127–140PubMedCrossRefGoogle Scholar
  41. Moore MM, Honma M, Clements J, Bolcsfoldi G, Burlinson B, Cifone M, Clarke J, Delongchamp R, Durward R, Fellows M, Gollapudi B, Hou S, Jenkinson P, Lloyd M, Majeska J, Myhr B, O’Donovan M, Omori T, Riach C, San R, Stankowski LF Jr, Thakur AK, Van Goethem F, Wakuri S, Yoshimura I (2006) Mouse lymphoma thymidine kinase gene mutation assay: follow-up meeting of the International Workshop on Genotoxicity Testing–Aberdeen, Scotland, 2003–Assay acceptance criteria, positive controls, and data evaluation. Environ Mol Mutagen 47(1):1–5PubMedCrossRefGoogle Scholar
  42. Moore MM, Honma M, Clements J, Bolcsfoldi G, Burlinson B, Cifone M, Clarke J, Clay P, Doppalapudi R, Fellows M, Gollapudi B, Hou S, Jenkinson P, Muster W, Pant K, Kidd DA, Lorge E, Lloyd M, Myhr B, O’Donovan M, Riach C, Stankowski LF Jr, Thakur AK, Van Goethem F, Mouse Lymphoma Assay Workgroup, IWGT (2007) Mouse lymphoma thymidine kinase gene mutation assay: meeting of the international workshop on genotoxicity testing, San Francisco, 2005, recommendations for 24-h treatment. Mutat Res 627(1):36–40, Epub 2006 Dec 6. PubMed PMID: 17157054PubMedCrossRefGoogle Scholar
  43. Moore MM, Honma M, Clements J, Awogi T, Douglas GR, van Goethem F, Gollapudi B, Kimura A, Muster W, O’Donovan M, Schoeny R, Wakuri S (2011) Suitable top concentration for tests with mammalian cells: mouse lymphoma assay workgroup. Mutat Res 723(2):84–86, Epub 2011 Apr 14. PubMed PMID: 21514400PubMedCrossRefGoogle Scholar
  44. Mortelmans K, Zeiger E (2000) The Ames Salmonella/microsome mutagenicity assay. Mutat Res 455:29–60PubMedCrossRefGoogle Scholar
  45. Müller L, Mauthe RJ, Riley CM, Andino MM, Antonis DD, Beels C, DeGeorge J, De Knaep AG, Ellison D, Fagerland JA, Frank R, Fritschel B, Galloway S, Harpur E, Humfrey CD, Jacks AS, Jagota N, Mackinnon J, Mohan G, Ness DK, O’Donovan MR, Smith MD, Vudathala G, Yotti L (2006) A rationale for determining, testing, and controlling specific impurities in pharmaceuticals that possess potential for genotoxicity. Regul Toxicol Pharmacol 44(3):198–211, Epub 2006 Jan 18. PubMed PMID: 16412543PubMedCrossRefGoogle Scholar
  46. Natarajan AT, Boei JJ (2004) Formation of chromosome aberrations: insights from FISH. Mutat Res 544:299–304Google Scholar
  47. Nüsse M, Beisker W, Kramer J, Miller B, Schreiber G, Viaggi S, Weller W-M, Wessels J-M (1994) Measurement of micronuclei by flow cytometry. Methods Cell Biol 42:149–158PubMedCrossRefGoogle Scholar
  48. OECD Guideline 475, Mammalian Bone Marrow Chromosome Aberration Test, adopted 21 July 1997Google Scholar
  49. OECD Guideline 476, In Vitro Mammalian Cell Mutation Test, adopted 21 July 1997Google Scholar
  50. OECD Guideline 486, Unscheduled DNA Synthesis (UDS) Test with Mammalian Liver Cells in vivo, adopted 21 July 1997Google Scholar
  51. OECD Guideline For Testing Of Chemicals, 471 Bacterial Reverse Mutation Test, adopted 21 July 1997Google Scholar
  52. OECD Guideline For Testing Of Chemicals, 473 “Genetic toxicology: in vitro mammalian chromosome aberration test”, adopted 21 July 1997Google Scholar
  53. OECD Guideline for Testing Of Chemicals, Draft Proposal For A New Guideline 487 In Vitro Micronucleus Test, adopted 22 July 2010Google Scholar
  54. Preston RJ, Dean BJ, Galloway S, Holden H, McFee AF, Shelby M (1987) Mammalian in vivo cytogenetic assays: analysis of chromosome aberrations in bone marrow cells. Mutat Res 189(2):157–165PubMedCrossRefGoogle Scholar
  55. Richold M, Chandley A, Ashby J, Gatehouse DG, Bootman J, Henderson L (1990) In vivo cytogenetic assays. In: Kirkland DJ (ed) Basic mutagenicity tests, UKEMS recommended procedures. UKEMS subcommitee on guidelines for mutagenicity testing. Report. Part I revised. Cambridge University Press, Cambridge/New York/Port Chester/Melbourne/Sydney, pp 115–141Google Scholar
  56. Rogers AW (1973) Technics of autoradiography. Elsevier Scientific, Amsterdam, p 218Google Scholar
  57. Romagna F, Staniforth C-D (1989) The automated bone marrow micronucleus test. Mutat Res 213:91–104PubMedCrossRefGoogle Scholar
  58. Rothfuss A, O’Donovan M, De Boeck M, Brault D, Czich A, Custer L, Hamada S, Plappert-Helbig U, Hayashi M, Howe J, Kraynak AR, van der Leede BJ, Nakajima M, Priestley C, Thybaud V, Saigo K, Sawant S, Shi J, Storer R, Struwe M, Vock E, Galloway S (2010) Collaborative study on fifteen compounds in the rat-liver comet assay integrated into 2- and 4-week repeat-dose studies. Mutat Res 702(1):40–69, Epub 2010 Jul 23. PubMed PMID: 20656055PubMedCrossRefGoogle Scholar
  59. Rothfuss A, Honma M, Czich A, Aardema MJ, Burlinson B, Galloway S, Hamada S, Kirkland D, Heflich RH, Howe J, Nakajima M, O’Donovan M, Plappert-Helbig U, Priestley C, Recio L, Schuler M, Uno Y, Martus HJ (2011) Improvement of in vivo genotoxicity assessment: combination of acute tests and integration into standard toxicity testing. Mutat Res 723(2):108–120, Epub 2010 Dec 21PubMedCrossRefGoogle Scholar
  60. Russo A (2000) In vivo cytogenetics: mammalian germ cells. Mutat Res 455:167–189PubMedCrossRefGoogle Scholar
  61. Salamone M, Heddle J, Stuart E, Katz M (1980) Towards an improved micronucleus test. Mutat Res 74:347–356PubMedCrossRefGoogle Scholar
  62. Schmid W (1975) The micronucleus test. Mutat Res 31:9–15PubMedCrossRefGoogle Scholar
  63. Seglen PO (1975) Preparation of isolated rat liver cells. Methods Cell Biol 13:29–83CrossRefGoogle Scholar
  64. Singh NP, McCoy MT, Tice RR, Schneider EL (1988) A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res 175:184–191PubMedCrossRefGoogle Scholar
  65. Sofuni T, Wilcox P, Shimada H, Clements J, Honma M, Clive D, Green M, Thybaud V, San R-H, Elliott B-M, Muller L (1997) Mouse lymphoma workshop: Victoria, British Columbia, Canada, March 27, 1996. Protocol issues regarding the use of the microwell method of the mouse lymphoma assay. Environ Mol Mutagen 29:434–438PubMedCrossRefGoogle Scholar
  66. Tice RR, Hayashi M, MacGregor JT, Anderson D, Blakey DH, Holden HE, Kirsch-Volders M, Oleson FB Jr, Pacchierotti F, Preston RJ, Romagna F, Shimada H, Sutou S, Vannier B (1994) Report from the working group on the in vivo mammalian bone marrow chromosome aberration test. Mutat Res 312:305–312PubMedCrossRefGoogle Scholar
  67. Tice RR, Agurell E, Anderson D, Burlinson B, Hartmann A, Kobayashi H, Miyamae Y, Rojas E, Ryu JC, Sasaki YF (2000) Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environ Mol Mutagen 35:206–221PubMedCrossRefGoogle Scholar
  68. U.S. EPA: OPPTS 870.5100 (1998) Health effects test guidelines bacterial reverse mutation testGoogle Scholar
  69. U.S. EPA: OPPTS 870.5375 (1998) Health effects test guidelines in vitro mammalian chromosome aberration testGoogle Scholar
  70. UKCOM (2000) Committee on Mutagenicity of Chemicals in Food, Consumer Products and the Environment. Guidance on a strategy for testing of chemicals for mutagenicity. Department of Health, UK. Environmental and Molecular Mutagenesis. doi:10.1002/em192. Available at http://www.advisorybodies.doh.gov.uk/com/guidance. pdf. Accessed 03 Sep 2011
  71. WHO. 2007. WHO/IPCS (World Health Organisation/International Programme on Chemical Safety). Draft guidance on mutagenicity testing for chemical risk assessment. Available at http://www.who.int/ipcs/methods/harmonization/areas/mutagenicity_testing. Accessed 03 Sep–Oct 2011
  72. Williams GM (1977) Detection of chemical carcinogens by unscheduled DNA synthesis in rat liver primary cell culture. Cancer Res 37:1845–1851PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2013

Authors and Affiliations

  1. 1.Dr. Stammberger - Toxicological Consulting ServicesHattersheim am MainGermany
  2. 2.Research & Development, Preclinical SafetySanofi GermanyFrankfurt am MainGermany
  3. 3.Mainz-KastelGermany

Personalised recommendations